# Apodex 1.1 vs Qwen3.6 Plus

> Side-by-side benchmark comparison for Apodex 1.1 and Qwen3.6 Plus across agentic, coding, multimodal, knowledge, reasoning, multilingual, and math tasks.

- Canonical page: https://benchlm.ai/compare/apodex-1-1-vs-qwen3-6-plus
- Last updated: October 9, 2026

- Shared sourced benchmarks: 2
- HTML indexing: indexable
- Ranking lane: BenchAlign v5.8

## Quick Verdict

Evidence is too thin for a benchmark verdict: Apodex 1.1 and Qwen3.6 Plus share only 2 sourced benchmark rows.

## Summary

- Only 2 shared sourced benchmark rows are available. That is not enough for a broad capability verdict, so this mirror does not name an overall winner.
- Qwen3.6 Plus has the larger published context window at 1M.

## Model Snapshot

| Property | Apodex 1.1 | Qwen3.6 Plus |
|----------|----------|----------|
| Creator | Apodex | Alibaba |
| Type | Proprietary | Proprietary |
| Reasoning | Reasoning | Reasoning |
| Context | N/A | 1M |
| Independent public score (not head-to-head) | 50.64 | 53.66 |
| Benchmarks Covered | 10 | 48 |
| Pricing (input/output) | Pricing unavailable / Pricing unavailable | Pricing unavailable / Pricing unavailable |

## Category Breakdown

### Agentic

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 45.4 (Estimated · #52/122)
- Qwen3.6 Plus public-lane score: 34.2 (Supported · #77/122)

| Benchmark | Apodex 1.1 | Qwen3.6 Plus | Winner |
|-----------|-----------|-----------|--------|
| Terminal-Bench 2.1 | 70.8% | Coming soon | Coming soon |
| HLE w/ tools | 56.1% | Coming soon | Coming soon |
| APEX-Agents | 38.5% | Coming soon | Coming soon |
| DeepSearchQA | 92.4% | Coming soon | Coming soon |
| Terminal-Bench 2.0 | Coming soon | 61.6% | Coming soon |
| Claw-Eval | Coming soon | 58.8% | Coming soon |
| QwenClawBench | Coming soon | 57.2% | Coming soon |
| τ³-bench results | Coming soon | 70.7% | Coming soon |
| VITA-Bench | Coming soon | 44.3% | Coming soon |
| DeepPlanning | Coming soon | 41.5% | Coming soon |
| Toolathlon | Coming soon | 39.8% | Coming soon |
| MCP Atlas | Coming soon | 48.2% | Coming soon |
| MCP-Tasks | Coming soon | 74.1% | Coming soon |
| WideResearch | Coming soon | 74.3% | Coming soon |
| Gert Labs | Coming soon | 50.60% | Coming soon |
| ResearchClawBench | Coming soon | 18.0% | Coming soon |
| Terminal-Bench 2.1 (Vals) | Coming soon | 53.2% | Coming soon |

### Coding

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 42.7 (Estimated · #59/146)
- Qwen3.6 Plus public-lane score: 41.3 (Supported · #61/146)

| Benchmark | Apodex 1.1 | Qwen3.6 Plus | Winner |
|-----------|-----------|-----------|--------|
| Terminal-Bench 2.1 | 70.8% | Coming soon | Coming soon |
| SWE-bench Verified | 77.7% | 78.8% | Qwen3.6 Plus |
| SWE-bench Pro | Coming soon | 56.6% | Coming soon |
| SWE Multilingual | Coming soon | 73.8% | Coming soon |
| LiveCodeBench v6 | Coming soon | 87.1% | Coming soon |
| Vibe Code Bench | Coming soon | 25.56% | Coming soon |
| LiveCodeBench (Vals) | Coming soon | 86.0% | Coming soon |
| SWE-bench (Vals) | Coming soon | 73.4% | Coming soon |

### Reasoning

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 76.8 (Unranked · 2 rankable rows)
- Qwen3.6 Plus public-lane score: 61.3 (Unranked · 4 rankable rows)

| Benchmark | Apodex 1.1 | Qwen3.6 Plus | Winner |
|-----------|-----------|-----------|--------|
| AI-Needle | Coming soon | 68.3% | Coming soon |
| LongBench v2 | Coming soon | 62% | Coming soon |

### Multimodal & Grounded

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 77.7 (Unranked · 1 rankable row)
- Qwen3.6 Plus public-lane score: 67.2 (#23/49)

| Benchmark | Apodex 1.1 | Qwen3.6 Plus | Winner |
|-----------|-----------|-----------|--------|
| MMMU | Coming soon | 86.0% | Coming soon |
| MMMU-Pro | Coming soon | 78.8% | Coming soon |
| MathVision | Coming soon | 88.0% | Coming soon |
| VideoMMMU | Coming soon | 84.0% | Coming soon |
| ScreenSpot Pro | Coming soon | 68.2% | Coming soon |
| CharXiv | Coming soon | 81.5% | Coming soon |
| V* | Coming soon | 96.9% | Coming soon |

### Knowledge

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 53.5 (Supported · #59/174)
- Qwen3.6 Plus public-lane score: 52.5 (Supported · #62/174)

| Benchmark | Apodex 1.1 | Qwen3.6 Plus | Winner |
|-----------|-----------|-----------|--------|
| HLE | 56.1% | 28.8% | Apodex 1.1 |
| FrontierScience Research | 63.3% | Coming soon | Coming soon |
| BioMysteryBench (human-difficult) | 35.3% | Coming soon | Coming soon |
| GPQA | Coming soon | 90.4% | Coming soon |
| SuperGPQA | Coming soon | 71.6% | Coming soon |
| MMLU-Pro | Coming soon | 88.5% | Coming soon |
| MMLU-Redux | Coming soon | 94.5% | Coming soon |
| C-Eval | Coming soon | 93.3% | Coming soon |
| GPQA Diamond (Vals) | Coming soon | 87.4% | Coming soon |
| MMLU-Pro (Vals) | Coming soon | 87.7% | Coming soon |

### Multilingual

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Qwen3.6 Plus public-lane score: 93.8 (#4/16)

| Benchmark | Apodex 1.1 | Qwen3.6 Plus | Winner |
|-----------|-----------|-----------|--------|
| MMLU-ProX | Coming soon | 84.7% | Coming soon |
| NOVA-63 | Coming soon | 57.9% | Coming soon |

### Instruction Following

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Qwen3.6 Plus public-lane score: 82.5 (#48/125)

| Benchmark | Apodex 1.1 | Qwen3.6 Plus | Winner |
|-----------|-----------|-----------|--------|
| IFEval | Coming soon | 94.3% | Coming soon |
| IFBench | Coming soon | 75.8% | Coming soon |

### Mathematics

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Qwen3.6 Plus public-lane score: 62 (#5/7)

| Benchmark | Apodex 1.1 | Qwen3.6 Plus | Winner |
|-----------|-----------|-----------|--------|
| IMO 2026 | 31/42 | Coming soon | Coming soon |
| AIME26 | Coming soon | 95.3% | Coming soon |
| HMMT Feb 2025 | Coming soon | 96.7% | Coming soon |
| HMMT Nov 2025 | Coming soon | 94.6% | Coming soon |
| HMMT Feb 2026 | Coming soon | 87.8% | Coming soon |
| MMAnswerBench | Coming soon | 83.8% | Coming soon |
| FrontierMath v2 (Tiers 1-3) | Coming soon | 26.207% | Coming soon |
| FrontierMath v2 (Tier 4) | Coming soon | 8.333% | Coming soon |

## FAQ

### Is there enough evidence to pick between Apodex 1.1 and Qwen3.6 Plus?

Not yet. The models share only 2 sourced benchmark rows, so this mirror reports the available measurements and metadata without naming a broad winner.

### What can I compare safely on this page?

Published pricing, context windows, model type, and individual shared benchmark rows are directly comparable. Independent overall scores and non-overlapping benchmark coverage are labeled separately and should not be read as a controlled head-to-head result.

## Related Comparisons

- [Apodex 1.1 vs Apodex 1.1 Mini](/compare/apodex-1-1-vs-apodex-1-1-mini)
- [Qwen3.6 Plus vs Apodex 1.1 Mini](/compare/apodex-1-1-mini-vs-qwen3-6-plus)
- [Apodex 1.1 vs Claude Opus 5.5](/compare/apodex-1-1-vs-claude-opus-5-5)
- [Qwen3.6 Plus vs Claude Opus 5.5](/compare/claude-opus-5-5-vs-qwen3-6-plus)

## Explore More

- [Apodex 1.1 profile](/models/apodex-1-1)
- [Qwen3.6 Plus profile](/models/qwen3-6-plus)
- [Compare Pricing](/llm-pricing)
- [Alternative Finder](/tools/alternative-finder)
- [LLM Selector](/tools/llm-selector)
- [Overall Rankings](/best/overall)